jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Dec. 04, 2012

Dec. 17, 2018

jRCT2080221972

Phase 2 Study to Evaluate Safety and Pharmacodynamics of CS-3150 in Type 2 Diabetes Mellitus Patients with Albuminuria

version:
date:

DAIICHISANKYO Co.,Ltd.

http://www.daiichisankyo.co.jp/corporate/rd/measure/clinical/index.html

Interventional

2

Main Inclusion Criteria;
-A diagnosis of Type 2 Diabetes Mellitus with Albuminuria
-Male and Female of 30 to 70 years of age
-Complication of Hypertension

Main Exclusion Criteria;
-Type 1 Diabetes Mellitus
-Patients with known Non-Diabetic Renal Disease

30age old over
70age old under

Both

Type 2 Diabetes Mellitus

investigational material(s)
Generic name etc : CS-3150
INN of investigational material :
Therapeutic category code : 214 Antihypertensives
Dosage and Administration for Investigational material : Oral

DAIICHISANKYO Co.,Ltd.

JapicCTI-122018

History of Changes

No Publication date
7 Dec. 17, 2018 (this page) Changes
6 July. 23, 2014 Detail Changes
5 July. 23, 2014 Detail Changes
4 July. 08, 2013 Detail Changes
3 July. 08, 2013 Detail Changes
2 Dec. 04, 2012 Detail Changes
1 Dec. 04, 2012 Detail